Achieve Reports Financial Results for Fourth Quarter and Year-End 2019 and Provides Update on Cytisinicline Development Program

Go back to Achieve Reports Financial Results for Fourth Quarter and Year-End 2019 and Provides Update on Cytisinicline Development Program
(NASDAQ: ACHV) Delayed: 6.48 -0.03 (0.46%)
Previous Close $6.51    52 Week High $ 
Open $6.39    52 Week Low $ 
Day High $6.64    P/E N/A 
Day Low $6.33    EPS $ 
Volume 664,928